Skip to main content

Table 1 Schedule of assessments

From: Efficacy and safety of levothyroxine (L-T4) replacement on the exercise capability in chronic systolic heart failure patients with subclinical hypothyroidism: Study protocol for a multi-center, open label, randomized, parallel group trial (ThyroHeart-CHF)

  1. HF heart failure, NT-proBNP N-terminal pro-brain natriuretic peptide, NYHA New York Heart Association, BMI body mass index, GPT glutamic-pyruvic transaminase, GOT glutamic oxaloacetic transaminase, TP total protein, ALB albumin, Tbil total bilirubin, Dbil direct bilirubin, CRP C-reactive protein, BUN blood urea nitrogen, Cr creatine, UA uric acid, GLU glucose, ALP alkaline phosphatase